Robert Pagels
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$3.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2023 | NSF | SBIR Phase II SBIR Phase II:Formulation of a mRNA-Based Therapy for CTLN1 by Inverse Flash NanoPrecipitation | $1.5M | Optimeos Life Sciences, Inc. |
| Jul 5, 2023 | NSF | SBIR Phase II SBIR Phase II: Formulation of a mRNA-Based Therapy for CTLN1 by Inverse Flash NanoPrecipitation | $1.5M | Optimeos Life Sciences, Inc. |
| Jun 1, 2022 | NIH | SBIR Phase I Highly loaded long-acting depots of therapeutic peptides | $288K | Optimeos Life Sciences, Inc. |
| Dec 15, 2020 | NSF | STTR Phase I STTR Phase I: Formulation of a COVID-19 mRNA Vaccine by Inverse Flash NanoPrecipitation | $256K | Optimeos Life Sciences, Inc. with Princeton University |
| Feb 1, 2019 | NSF | STTR Phase I STTR Phase I: Sustained Delivery of Peptides with Inverse Flash Nanoprecipitation | $225K | Optimeos Life Sciences, Inc. with Princeton University |
Peer ranks
Federal funding#432
Awards as PI#417
Patents#273
Companies
- Optimeos Life Sciences, Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.